Cherison Cuffy
Foot & Ankle Surgery · North Miami Beach, FLNPI 1407081813
Payments from drug & device makers
Across 319 payments — averaging $49.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$4K
- Southern Edge Orthopaedics, Inc.$2K
- Organogenesis Inc.$2K
- Stryker$2K
- Integra Lifesciences Corporation$986
- Orthofix Medical, Inc.$914
- plus $5K from 29 others
What the payments were for
- Consulting fees$1,5009%
- Travel & lodging$7114%
- Food & beverage$11,72774%
- Education$1,87312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 89 | $3,924 |
| Southern Edge Orthopaedics, Inc. | 3 | $2,058 |
| Organogenesis Inc. | 57 | $1,513 |
| Stryker(2 entities) | 17 | $1,509 |
| Integra Lifesciences Corporation | 27 | $986 |
| Orthofix Medical, Inc. | 8 | $914 |
| Kerecis Limited | 17 | $706 |
| Amgen(2 entities) | 10 | $457 |
| KCI USA, Inc. | 8 | $368 |
| Biotissue Holdings Inc. | 3 | $330 |
| Solventum Corporation | 3 | $299 |
| Johnson & Johnson | 4 | $248 |
| Nevro Corp. | 3 | $234 |
| Polynovo North America LLC | 4 | $216 |
| Misonix Inc | 19 | $208 |
| Paratek Pharmaceuticals, Inc. | 5 | $185 |
| Mimedx Group, Inc. | 2 | $176 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $165 |
| Aroa Biosurgery Incorporated | 4 | $156 |
| Urgo Medical North America, LLC | 2 | $139 |
| Osiris Therapeutics Inc. | 7 | $128 |
| Lifenet Health | 1 | $106 |
| Cook Medical LLC | 1 | $104 |
| Paragon 28, Inc. | 1 | $93 |
| Globus Medical | 1 | $80 |
| Kowa Pharmaceuticals America, Inc. | 4 | $79 |
| Melinta Therapeutics, LLC | 4 | $77 |
| Medtronic | 2 | $77 |
| Treace Medical Concepts, Inc. | 3 | $73 |
| ETS Wound Care LLC | 3 | $64 |
| Innovation Technologies Inc | 2 | $62 |
| Trilliant Surgical LLC. | 1 | $23 |
| Acell, Inc. | 1 | $20 |
| Acera Surgical, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COLLAGENASE SANTYL$1,500
- Kerecis SurgiClose$1,453
- Stravix$722
- TrueLok$684
- GRAFIX PL$609
- SALVATION$558
- INTEGRA$433
- PRIMATRIX$394
- INTEGRA DERMAL REGENERATION TEMPLATE$394
- STRAVIX PL$392
- Kerecis GraftGuide$363
- OASIS MICRO$362
- NEOX$330
- Grafix$258
- GrafixPL$258
- INTEGRA MESHED BILAYER WOUND MATRIX$249
- INTEGRA WOUND MATRIX (IWM)$249
- INTEGRA FLOWABLE WOUND MATRIX$249
- Oasis$244
- Apligraf$233
How this compares
$15,811 in reported general payments places this provider in the 85th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 25 | $15,149 |
| Gentamicin Sulfate | 24 | $656 |
| Mupirocin | 36 | $337 |
| Doxycycline Hyclate | 45 | $272 |
| Ammonium Lactate | 18 | $261 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $92 |
| Terbinafine Hcl | 11 | $81 |
| Ciprofloxacin Hcl | 11 | $72 |
| Ibuprofen | 12 | $62 |
| Tramadol Hcl | 14 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $3,924 | $15,14925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 850 foot & ankle surgery providers in Florida.
Other foot & ankle surgery in North Miami Beach
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
- Christopher ReevesLake Mary$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.